Services

We provide a comprehensive set of quantitative imaging services for oncologic clinical trials, in particular for evaluation of responses to cancer therapies.

Our services are always built around the highest standards, following International Conference on Harmonisation (ICH), Good Clinical Practices (GCP) and FDA guidelines.

Consultation

We offer trial design and development services as part of our total solution package. Our imaging and oncology experts are always available to you for consultation. Our sub-specialized expert radiologists, who have served in the ACR Appropriateness Criteria-Expert Panel committees, will provide detailed and informative answers to all your questions to meet the needs of your clinical trial goals.

Image Analysis

Image analysis is performed by a highly qualified team of radiologists and imaging professionals who undergo a systematic training and evaluation.

Our imaging services in Oncology include response to therapy assessment for various cancers:

  • Breast
  • Colon
  • Head and Neck
  • Liver
  • Lung
  • Lymphoma
  • Pancreatic
  • Prostate
  • Sarcoma

We provide 2D, 3D, and 4D image analysis capabilities for various study types:

The QICL makes quantitative measurements of lesions according to accepted techniques and assessment criteria standards such as:

  • RECIST 1.0 and 1.1
  • mRECIST
  • Volumetric size and density
  • Immune Related RECIST
  • Immune Related Response Criteria
  • PERCIST
  • EASL
  • WHO
  • Cheson
  • CHOI
  • McDonald
  • RANO

Imaging Protocol Development

Our leading experts in radiology and oncology can exclusively tailor an Imaging Protocol for your clinical trial to satisfy all your study objectives and maximize the effectiveness of image analyses in therapy assessment.

Imaging Biomarker Services

The QICL is actively supporting efforts to develop and promote novel Imaging Biomarkers for assessing response to therapy in oncology. We can help you to decide which set of Imaging Biomarkers is right for your clinical trial.